Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
05 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250605057671/en/Viridian-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
30 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250530073339/en/Viridian-Therapeutics-to-Participate-in-Upcoming-June-Investor-Conferences
20 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250520329293/en/Viridian-Therapeutics-Announces-Positive-Long-Term-Durability-Data-from-the-Veligrotug-Phase-3-THRIVE-Clinical-Trial-in-Patients-with-Active-Thyroid-Eye-Disease-TED
07 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250507164030/en/Viridian-Therapeutics-Receives-FDA-Breakthrough-Therapy-Designation-for-Veligrotug-for-the-Treatment-of-Thyroid-Eye-Disease-TED
06 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250506203388/en/Viridian-Therapeutics-Highlights-Recent-Progress-and-Reports-First-Quarter-2025-Financial-Results
02 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250502285816/en/Viridian-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4
ABOUT THIS PAGE